Home › Funds › Birchview Capital, LP › DRUG
Birchview Capital, LP position in DRUG
BRIGHT MINDS BIOSCIENCES INC · Health Care
Birchview Capital, LP reported holding 15,400 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$767K, representing 0.46% of its reported portfolio and ranking #43 among its reported holdings. Birchview Capital, LP first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Birchview Capital, LP's DRUG position evolved
Birchview Capital, LP first disclosed a stake in DRUG in Q3 2026 at 15,400 shares (US$767K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 15.40K | $767.23K | New |
About DRUG and 13F data
DRUG (BRIGHT MINDS BIOSCIENCES INC) is a Health Care company. 71 other funds we track also report a position in DRUG — the largest reported positions include Cormorant Asset Management, LP (US$63.2M), Vestal Point Capital, LP (US$38.3M), BRAIDWELL LP (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DRUG
- Cormorant Asset Management, LP 900.00K sh · $63.18M · Q2 2026
- Vestal Point Capital, LP 545.00K sh · $38.26M · Q2 2026
- BRAIDWELL LP 483.82K sh · $33.96M · Q2 2026
- Vivo Capital, LLC 417.88K sh · $20.82M · Q3 2026
- Parkman Healthcare Partners LLC 205.05K sh · $14.39M · Q2 2026
- MPM BioImpact LLC 202.11K sh · $14.19M · Q2 2026
- GREAT POINT PARTNERS LLC 109.60K sh · $7.69M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 92.75K sh · $6.51M · Q2 2026
- Ikarian Capital, LLC 88.95K sh · $6.24M · Q2 2026
- Sio Capital Management, LLC 73.95K sh · $5.19M · Q2 2026
- B Group, Inc. 67.50K sh · $4.74M · Q2 2026
- Artia Global Partners LP 38.41K sh · $2.70M · Q2 2026
More on Birchview Capital, LP
FAQ
How long has Birchview Capital, LP held DRUG?
Birchview Capital, LP has disclosed DRUG holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Birchview Capital, LP's current position in DRUG?
As of Q3 2026, Birchview Capital, LP holds 15.40K shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), valued at $767.23K, representing 0.46% of its reported portfolio and ranking #43.
Has Birchview Capital, LP been buying or selling DRUG?
In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in DRUG.
Which other funds hold DRUG?
Other major institutional holders of DRUG include Cormorant Asset Management, LP, Vestal Point Capital, LP, BRAIDWELL LP, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.